Healthcare & Life Sciences
Octimet Oncology NV
Germanyoctimet.com
Octimet Oncology NV is a Healthcare & Life Sciences startup based in Germany, most recent round Series A, 1 tracked investor.
series-a
series-a
Stage
1
Investors
About Octimet Oncology NV
Octimet Oncology NV is a company headquartered in Germany. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Octimet Oncology NV develops targeted cancer therapies by designing selective inhibitors such as OMO-1, a MET kinase inhibitor, and OMO-2, a dual MET and RAS pathway inhibitor, focusing primarily on lung cancer and other oncology indications.
Explore Octimet Oncology NV's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.